Safety and Efficacy of OP2000 (Deligoparin) in the Treatment of Active Ulcerative Colitis

Daniel H. Present, MD, New York

Long Island Clinical Research Associates, Great Neck

Hospital of the Univ. of Pennsylvania, Philadelphia

Metropolitan Gastroenterology Group, Chevy Chase

Univ. of Virginia Health System, Charlottesville

Univ. of North Carolina Hospital, Chapel Hill

Wake Research Associates, LLC, Raleigh

Duke Health Center, Durham

Charlotte Gastroenterology & Hepatology, PLLC, Charlotte

Atlanta Gastroenterology Associates, LLC, Atlanta

Borland-Groover Clinic, Jacksonville

University of Florida Gainesville/Gainesville VAMC, Gainesville

University of Miami, Division of Clinical Pharmacology, Miami

Miami Research Associates, Miami

Nashville Clinical Research, Nashville

Memphis Gastroenterology Group, PC, Memphis

Univ. of Kentucky Medical Center, Lexington

Cleveland Clinic Foundation, Cleveland

Consultants for Clinical Research, Cincinnati

University of Michigan Health System, Ann Arbor

Wisconsin Center for Advanced Research, LLC, Milwaukee

Minnesota Clinical Research Center, Saint Paul

Washington Univ. School of Medicine, St Louis

Gastroenterology Specialties, PC, Lincoln

Oklahoma Foundation for Digestive Research, Oklahoma City

Gastroenterology United of Tulsa, Tulsa

GANT Research, PA, Fort Worth

Gastroenterology Clinic of San Antonio, San Antonio

Rocky Mountain Clinical Research, Littleton

Rocky Mountain Gastroenterology Associates, Lakewood

AGMG Clinical Research, Anaheim

Community Clinical Trials, Orange

West Hills Gastroenterology, Portland